Back to search
BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer trials you may qualify forThis is a single arm phase 1b/2 evaluation of the combination of oregovomab, and bevacizumab, paclitaxel carboplatin in adult subjects with CA125-associated, ad…
The aim of the study is to explore a prognostic clinical and molecular biomarker profile in a population of BRCA wild-type recurrent high-grade ovarian cancer p…
This study is phase II, open label, clinical trial to determine the efficacy of Olaparib maintenance with Bevacizumab and Pembrolizumab by assessment progressio…